Shields J A, Shields C L, Donoso L A, Lieb W E
Ocular Oncology Service, Wills Eye Hospital, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa 19107.
Ophthalmic Surg. 1990 Jan;21(1):72-6.
For many years the most common treatment for retinoblastoma has been enucleation, generally performed on the affected eye in children with unilateral sporadic disease and on the more severely affected eye in children with bilateral disease. With refinements in conservative treatment methods, however, the affected eye now often may be salvaged and useful vision retained. Emphasizing this trend, we present our current approaches to managing retinoblastoma based on our experience with 324 patients, outlining our indications and pointing out a number of misconceptions about the role of enucleation, photocoagulation, cryotherapy, and radiotherapy in treating this condition. We also sketch some recent findings regarding the genetics of retinoblastoma and consider ways in which such research may lead to improved management of the disease.
多年来,视网膜母细胞瘤最常见的治疗方法是眼球摘除术,通常用于患有单侧散发性疾病的儿童的患眼,以及患有双侧疾病的儿童中受影响更严重的眼睛。然而,随着保守治疗方法的改进,现在患眼常常可以得到挽救并保留有用的视力。为强调这一趋势,我们根据对324例患者的经验,介绍我们目前处理视网膜母细胞瘤的方法,概述我们的适应症,并指出有关眼球摘除术、光凝疗法、冷冻疗法和放射疗法在治疗这种疾病中作用的一些误解。我们还简述了有关视网膜母细胞瘤遗传学的一些最新发现,并探讨这类研究可能改善该疾病治疗的方式。